Entity of excessive daytime sleepiness in Parkinson’s disease
Objective: To examine frequency and reasons of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Neurodegeneration and dopaminergic medications are known to…Complex disease burden in Parkinson’s and Advance Care Planning
Objective: To evaluate if Advanced Care Planning is completed in patients with complex stage of Parkinson’s Disease (PD). Background: NICE (National Institute of Health and…Is the activation ratio of transversus abdominis associated with mobility and core endurance in patients with Idiopathic Parkinson’s Disease?: A Preliminary study
Objective: This study aims to investigate the relationship between the transversus abdominis (TrA) muscle thickness changes using the activation ratio during abdominal drawing-in maneuver (ADIM)…Does cognitive-motor training improve the balance in Parkinson’s disease? Randomized clinical trial
Objective: To verify the effectiveness of adding cognitive training to motor physiotherapy compared to motor physiotherapy in balance, motor symptoms and activities of daily living…Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients
Objective: To evaluate the extent to which data derived from smartphone-based testing and passive monitoring are related to what recently diagnosed Parkinson’s disease (PD) patients…Correlation between Pareidolia and cerebral perfusion by SPECT in Parkinson’s disease without dementia: A retrospective study
Objective: The aim of this study is to investigate the correlation between the number of illusory responses on the Pareidolia test and cerebral perfusion in…The Efficacy and Safety of Subcutaneous Apomorphine in Patients with Parkinson’s Disease: A Meta-Analysis Randomized Controlled Trials
Objective: The objective of this study to evaluate the efficacy and safety of subcutaneous apomorphine for patients with Parkinson’s disease (PD). Background: Subcutaneous apomorphine has…The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…CHCHD2 maintains the MICOS and inhibits PINK1/Parkin mediated mitophagy in an experimental model of Parkinson’s disease
Objective: To illustrate the mechanism of CHCHD2 in regulating MICOS and mitophagy in Parkinson's disease.To illustrate the mechanism of CHCHD2 in regulating MICOS and mitophagy…Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India
Objective: We intended to assess presence of cervical and lumbosacral spondylosis our patients with parkinsonism. Background: We have observed that patients with Parkinson’s disease [PD]…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 405
- Next Page »